EFFECTS OF SIMVASTATIN AND CHOLESTYRAMINE ON LIPOPROTEIN PROFILE IN HYPERLIPIDAEMIA OF NEPHROTIC SYNDROME
- 1 December 1988
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 332 (8624), 1335-1338
- https://doi.org/10.1016/s0140-6736(88)90870-7
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Focal and segmental glomerulosclerosis: Analogies to atherosclerosisKidney International, 1988
- Treatment of hyperlipidemia reduces glomerular injury in obese Zucker ratsKidney International, 1988
- Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure.Circulation Research, 1988
- Exacerbation of chronic aminonucleoside nephrosis by dietary cholesterol supplementationKidney International, 1987
- Effect of Probucol on Hyperlipidemia in Patients with Nephrotic SyndromeNephron, 1987
- Treatment of the Hyperlipidemia of the Nephrotic Syndrome: A Controlled TrialAmerican Journal of Kidney Diseases, 1986
- The Hyperlipidemia of the Nephrotic SyndromeNew England Journal of Medicine, 1985
- Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.Journal of Clinical Investigation, 1984
- The Nephrotic Syndrome and Ischaemic Heart DiseaseNephron, 1981
- Status of the coronary arteries in the nephrotic syndromeThe American Journal of Medicine, 1977